BIOMAT Database Logo BIOMAT Database Logo

[Contemporary approaches to the treatment of arterial hypertension and ischemic heart disease]. 2006

E V Sorokin

Prognostic advantage of a combination of calcium antagonist and angiotensin converting inhibitor (ACEI) over combination of beta-adrenoblocker with thiazide diuretic was proved in a large randomized study of long term treatment of arterial hypertension. In another randomized study administration of ACEI for 12 months caused substantial retardation of cardiac remodeling in elderly patients with normal left ventricular function in postinfarction period. These results are important for a practical physicians as they concern treatment of wide circle of in- out-patients.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D002309 Cardiology The study of the heart, its physiology, and its functions. Angiology,Cardiovascular Disease Specialty,Vascular Medicine,Disease Specialty, Cardiovascular,Medicine, Vascular,Specialty, Cardiovascular Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017202 Myocardial Ischemia A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION). Heart Disease, Ischemic,Ischemia, Myocardial,Ischemic Heart Disease,Disease, Ischemic Heart,Diseases, Ischemic Heart,Heart Diseases, Ischemic,Ischemias, Myocardial,Ischemic Heart Diseases,Myocardial Ischemias

Related Publications

E V Sorokin
[Pumpan in the treatment of ischemic heart disease associated with arterial hypertension].
January 2001, Terapevticheskii arkhiv,
E V Sorokin
Arterial hypertension, microalbuminuria, and risk of ischemic heart disease.
April 2000, Hypertension (Dallas, Tex. : 1979),
E V Sorokin
Treatment of hypertension and ischemic heart disease.
January 1989, Journal of cardiovascular pharmacology,
E V Sorokin
[Treatment of hypertension and ischemic heart disease].
August 1985, Vnitrni lekarstvi,
E V Sorokin
[Arterial hypertension and ischemic heart disease: clinico-echocardiographic aspects].
January 2003, Klinicheskaia meditsina,
E V Sorokin
[Prevalence of arterial hypertension, ischemic heart disease and the environmental factors].
October 1967, Kardiologiia,
E V Sorokin
[Arterial hypertension and ischemic heart disease in workers exposed to local vibration].
January 2005, Meditsina truda i promyshlennaia ekologiia,
E V Sorokin
Arterial Hypertension and Ischemic Heart Disease: Comparison in Epidemiological Studies.
June 1963, Canadian Medical Association journal,
E V Sorokin
[Compliance to treatment of arterial hypertension and ischemic heart disease - key condition of lowering of cardiovascular mortality].
January 2007, Kardiologiia,
E V Sorokin
[Arterial tonus in men 40 to 59 with hypercholesterolemia, arterial hypertension and ischemic heart disease].
January 1986, Terapevticheskii arkhiv,
Copied contents to your clipboard!